Bret Weinstein on health: what the evidence says · JRE #2198
SUBJECT: HEALTH
The short answer
Weinstein states that Dr. Pierre Kory lost (or is in the process of losing) his medical license as punishment for promoting ivermectin. Wisconsin's Department of Safety and Professional Services, where Kory is licensed in Medicine and Surgery, lists his credential as active and current through October 31, 2027, with no indication of suspension or revocation; public reporting indicates his licenses in other states have similarly remained unaffected.
Not a true/false call. Every claim is logged with its sources; read the exhibits below.
Yeah, I believe so, or it's in process. But they are punishing him for talking about a beneficial medicine that happens to not be patentable.
What the evidence says 01 / RECORD
Weinstein claimed Pierre Kory has lost, or is losing, his medical license as punishment for promoting ivermectin. Wisconsin's Department of Safety and Professional Services, where Kory is licensed in Medicine and Surgery, lists his credential as active and current through October 31, 2027, with no indication of suspension or revocation; public reporting indicates his licenses in other states have similarly remained unaffected. What Kory did lose, in August 2024, was his board certifications in internal medicine, pulmonary disease and critical care, revoked by the American Board of Internal Medicine (ABIM), a private specialty organization distinct from state medical licensing boards, after an ABIM panel found he had made false or misleading public statements about ivermectin's ability to treat COVID-19; board certification is not required to hold a medical license or practice independently. Independent evidence also does not support characterizing ivermectin as simply a "beneficial medicine": a Cochrane systematic review (updated 2022, 11 randomized trials, 3,409 participants) found moderate- to high-certainty evidence that ivermectin has no beneficial effect on mortality or recovery in COVID-19 outpatients, and very low- to low-certainty evidence in hospitalized patients, concluding available evidence does not support its use for COVID-19 outside well-designed trials. The claim conflates a professional certification action with license revocation and overstates the evidence base for ivermectin's benefit.